IL-15/IL-15Ra/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. (2018)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2018019026

PubMed Identifier: 30482760

Publication URI: http://europepmc.org/abstract/MED/30482760

Type: Journal Article/Review

Volume: 2

Parent Publication: Blood advances

Issue: 22

ISSN: 2473-9529